Shuttle Pharmaceuticals, Inc. announced it raised $120,000 in an initial filing from an offering of $120,000

Company

Location

About

Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT). Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma's mission is to improve the lives of cancer patients by developing therapies that are designed to maximize the effectiveness of RT while limiting the side effects of radiation in cancer treatment.